Anne-Marie Privat
Overview
Explore the profile of Anne-Marie Privat including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
183
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wattiez A, Dupuis A, Privat A, Chalus M, Chapuy E, Aissouni Y, et al.
Neuropharmacology
. 2017 Aug;
125:308-318.
PMID: 28780039
Antidepressants remain one of the first line treatments prescribed to neuropathic pain patients despite their limited efficacy and/or their numerous side effects. More and more, pharmacotherapy for neuropathic pain has...
2.
Morel V, Pickering G, Etienne M, Dupuis A, Privat A, Chalus M, et al.
Fundam Clin Pharmacol
. 2014 Apr;
28(6):671-80.
PMID: 24702319
N-methyl-D-aspartate receptor (NMDAR) antagonists may be given in persistent neuropathic pain, but adverse events especially with ketamine may limit their clinical use. Less central and cognitive adverse events are described...
3.
Wattiez A, Pichon X, Dupuis A, Hernandez A, Privat A, Aissouni Y, et al.
PLoS One
. 2013 Sep;
8(9):e74661.
PMID: 24058620
Despite common pathophysiological mechanisms, inflammatory and neuropathic pain do not respond equally to the analgesic effect of antidepressants, except for selective serotonin reuptake inhibitors (SSRIs), which show a limited efficacy...
4.
Morel V, Etienne M, Wattiez A, Dupuis A, Privat A, Chalus M, et al.
Eur J Pharmacol
. 2013 Jul;
721(1-3):382-90.
PMID: 23810967
N-methyl-D-aspartate (NMDA) receptor antagonists are used for post-surgery neuropathic pain but severe side-effects limit their clinical use. Memantine, when given after surgery, shows conflicting results as regard to neuropathic pain...
5.
Daulhac L, Maffre V, Mallet C, Etienne M, Privat A, Kowalski-Chauvel A, et al.
Eur J Pain
. 2010 Jul;
15(2):169.e1-169.e12.
PMID: 20594879
The N-methyl-d-aspartate receptor (NMDAR) contributes to central sensitization in the spinal cord, a phenomenon which comprises various pathophysiological mechanisms responsible for neuropathic pain-like signs in animal models. NMDAR function is...
6.
Courteix C, Privat A, Pelissier T, Hernandez A, Eschalier A, Fialip J
J Pharmacol Exp Ther
. 2007 Jun;
322(3):1237-45.
PMID: 17551093
Agmatine, an endogenous cationic amine resulting from the decarboxylation of L-arginine, produces antihyperalgesic and antiallodynic effects in animal models of chronic neuropathic and inflammatory pain. We examined the effect of...
7.
Daulhac L, Mallet C, Courteix C, Etienne M, Duroux E, Privat A, et al.
Mol Pharmacol
. 2006 Jul;
70(4):1246-54.
PMID: 16868181
Molecular mechanisms underlying diabetes-induced painful neuropathy are poorly understood. We have demonstrated, in rats with streptozotocin-induced diabetes, that mechanical hyperalgesia, a common symptom of diabetic neuropathy, was correlated with an...
8.
Courteix C, Coudore-Civiale M, Privat A, Pelissier T, Eschalier A, Fialip J
Pain
. 2004 Jul;
110(1-2):236-45.
PMID: 15275773
Nociceptin/orphanin FQ (noci/OFQ), the endogenous ligand for the orphan ORL1 (opioid receptor-like1), has been shown to be anti- or pronociceptive and modify morphine analgesia in rats after central administration. We...